Risk of Stent Stenosis after Implanting a First-Generation Drug-Eluting Stent and Drug Balloon Angioplasty.
10.3904/kjm.2015.88.6.690
- Author:
Okgeun KIM
1
;
Il RHEE
;
Jigeon JANG
;
Wonil SONG
;
Jonghyun LEE
;
Minsung KIM
Author Information
1. Division of Cardiology, Department of Internal Medicine, Good Samsun Hospital, Busan, Korea. cormed21@gmail.com
- Publication Type:Case Report
- Keywords:
Stent thrombosis;
In-stent restenosis;
Drug balloon angioplasty
- MeSH:
Angioplasty, Balloon*;
Constriction, Pathologic*;
Coronary Artery Disease;
Coronary Vessels;
Drug-Eluting Stents*;
Follow-Up Studies;
Humans;
Stents*;
Thrombosis
- From:Korean Journal of Medicine
2015;88(6):690-695
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In patients with coronary artery disease, coronary stenting with a drug-eluting stent (DES) is associated with lower rates of in-stent restenosis and re-surgery for the target lesion compared with a bare metal stent, while late stent thrombosis has emerged as a life-threatening complication in patients treated with a first-generation DES. As no treatment has been established for potentially fatal late stent thrombosis associated with a first-generation DES, we perform drug balloon angioplasty for patients with stent thrombosis and in-stent restenosis associated with DES. Here, we reported the cases with normal coronary artery flow after a 2-year follow-up.
